Your browser doesn't support javascript.
loading
Prognostic and predictive value of ß-blockers in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma.
Kennedy, Oliver J; Kicinski, Michal; Valpione, Sara; Gandini, Sara; Suciu, Stefan; Blank, Christian U; Long, Georgina V; Atkinson, Victoria G; Dalle, Stéphane; Haydon, Andrew M; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Di Giacomo, Anna M; van den Eertwegh, Alfonsus J M; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; van Akkooi, Alexander C J; Robert, Caroline; Eggermont, Alexander M M; Lorigan, Paul; Mandala, Mario.
Affiliation
  • Kennedy OJ; University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom. Electronic address: ojk@doctors.org.uk.
  • Kicinski M; EORTC Headquarters, Brussels, Belgium.
  • Valpione S; Cancer Research UK Manchester Institute, Manchester and the Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Gandini S; Molecular and Pharmaco-Epidemiology Unit, European Institute of Oncology, IRCCS, Milano, Italy.
  • Suciu S; EORTC Headquarters, Brussels, Belgium.
  • Blank CU; Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands.
  • Long GV; Melanoma Institute Australia, The University of Sydney, And Mater and Royal North Shore Hospitals, Sydney, NSW, Australia.
  • Atkinson VG; Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Dalle S; Hospices Civils de Lyon Cancer Institute, Lyon, France.
  • Haydon AM; Alfred Hospital, Melbourne, VIC, Australia.
  • Meshcheryakov A; NN Blokhin Cancer Research Center, Moscow, Russian Federation.
  • Khattak A; Fiona Stanley Hospital & Edith Cowan University, Perth, WA, Australia.
  • Carlino MS; Westmead and Blacktown Hospitals, Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia.
  • Sandhu S; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Larkin J; Royal Marsden Hospital, London, United Kingdom.
  • Puig S; Hospital Clinic de Barcelona, Universitat de Barcelona, Spain &Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain.
  • Ascierto PA; Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy.
  • Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Schadendorf D; University Hospital Essen, Essen and German Cancer Consortium, Heidelberg, Germany.
  • Koornstra R; Radboud University Medical Center Nijmegen, Nijmegen, Netherlands.
  • Hernandez-Aya L; Washington University School of Medicine, St. Louis, MO, USA.
  • Di Giacomo AM; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy.
  • van den Eertwegh AJM; Amsterdam University Medical Center, Location VUMC, Amsterdam, Netherlands.
  • Grob JJ; Aix Marseille University, Hôpital de la Timone, Marseille, France.
  • Gutzmer R; Skin Cancer Center, Hannover Medical School, Hannover, and Department of Dermatology, Johannes Wesling Klinikum Minden, Ruhr University Bochum, Minden, Germany.
  • Jamal R; Centre Hospitalier de l'Université de Montréal (CHUM), Centre de recherche du CHUM, Montreal, QC, Canada.
  • van Akkooi ACJ; Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands.
  • Robert C; Gustave Roussy and Paris-Saclay University, Villejuif, France.
  • Eggermont AMM; Comprehensive Cancer Center Munich, Munich, Germany; Princess Máxima Center and University Medical Center Utrecht, Utrecht, Netherlands.
  • Lorigan P; Division of Cancer Sciences, University of Manchester and Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Mandala M; University of Perugia, Santa Maria Misericordia Hospital, Perugia, Italy.
Eur J Cancer ; 165: 97-112, 2022 04.
Article in En | MEDLINE | ID: mdl-35220182
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur J Cancer Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur J Cancer Year: 2022 Document type: Article